Sleeping significantly longer than average may be an early warning sign of Alzheimer's disease, according to new research published in Alzheimer's and Dementia. Scientists found that people who slept more than 8.5 hours per night had higher blood levels of phosphorylated tau (p-tau181), a protein associated with brain changes linked to dementia. However, experts emphasize this doesn't mean long sleep causes Alzheimer's, and the relationship is far more complex than it appears.

What Does the Research Show About Sleep and Alzheimer's?

Researchers analyzed data from 2,410 participants in the Framingham Heart Study, with an average age of 70. All participants reported their typical sleep duration and provided blood samples for biomarker analysis. The study found that phosphorylated tau levels followed a distinctive pattern: they were elevated in short sleepers (up to 6 hours), dipped in average sleepers (6 to 9 hours), then climbed steadily in long sleepers, rising sharply for those reporting 10 or more hours of sleep.

Of the study group, 23.9% reported short sleep, 61.2% reported average sleep, and 14.9% reported long sleep. Those sleeping longer were older and more likely to have depression, use antidepressants, and have dementia than average sleepers. All four blood biomarkers measured in the study tended to increase with longer sleep, but only the increase in p-tau181 reached statistical significance.

How Should People Interpret These Findings?

The critical question is whether long sleep causes Alzheimer's changes or reflects them. Experts believe the answer is likely the latter. Alzheimer's disease begins silently in the brain 15 to 20 years before symptoms appear, and the earliest pathological changes may affect brain regions that regulate the sleep-wake cycle. As a result, people may gradually begin sleeping longer before they notice any memory problems.

"This study strengthens growing evidence that changes in sleep may be linked to the earliest biological processes involved in Alzheimer's disease, rather than simply being a consequence of aging. What is particularly interesting here is the association between longer sleep and higher levels of plasma phosphorylated tau (p-tau181), a biomarker that reflects Alzheimer's pathology," said Steven Allder, MD, a consultant neurologist at Re:Cognition Health.

Steven Allder, MD, Consultant Neurologist at Re:Cognition Health

Long sleep may also reflect poor sleep quality rather than actual rest. Someone spending nine or ten hours in bed may experience fragmented or inefficient sleep, repeatedly waking throughout the night without full awareness. Deep, restorative sleep plays an important role in clearing waste products, including amyloid proteins, from the brain through the glymphatic system. Fragmented sleep may impair these restorative processes.

The study itself cannot prove causation because it captured a single snapshot in time rather than following participants over years. Researchers would need long-term prospective studies that recruit cognitively healthy individuals, measure Alzheimer's biomarkers at baseline, and then track changes in sleep over many years to determine whether long sleep is a cause or an early symptom.

Why Blood Biomarkers Matter, But Don't Tell the Whole Story

The discovery of p-tau217 and p-tau181 in blood has generated excitement in neuroscience because these tests offer a less invasive alternative to expensive brain imaging like PET scans. In May 2025, the FDA cleared the first blood test to aid in diagnosing Alzheimer's disease in people already showing signs of cognitive decline. However, the FDA specifically states the test is not intended as a screening tool for apparently healthy people or as a stand-alone diagnosis.

A separate study published in JAMA in July 2026 examined whether p-tau217 could predict cognitive decline in cognitively unimpaired older adults. Researchers pooled data from 2,684 participants across six studies in North America, Japan, and Australia, followed for a median of 5.4 years. They found that for every one-standard-deviation increase in p-tau217, the relative risk of progressing to cognitive impairment rose by 38%. When translated into absolute risk over five years, the findings were more modest:

• Low p-tau217 group: About 12% risk of developing cognitive impairment over five years
• Intermediate p-tau217 levels: About 15% risk of cognitive impairment over five years
• High p-tau217 levels: Approximately 24% risk of cognitive impairment over five years
• Very high p-tau217 levels: An estimated 38% risk of cognitive impairment over five years

Even among people with very high p-tau217, approximately 62% did not progress to cognitive impairment during the five-year period. Conversely, even the low p-tau217 group had a 12% risk of cognitive decline. This tells us that p-tau217 is detecting something important, but it is not telling the whole story.

Steps to Support Brain Health While Research Continues

• Maintain consistent sleep patterns: Aim for 7 to 9 hours of quality sleep per night, and monitor whether you're sleeping significantly longer than usual, as this may warrant discussion with a healthcare provider
• Prioritize sleep quality over quantity: Focus on deep, restorative sleep by maintaining a cool bedroom, limiting screen time before bed, and addressing sleep disorders like obstructive sleep apnea if present
• Combine sleep with other protective factors: Dementia is influenced by a complex relationship of genetics, vascular health, lifestyle, and aging. Alongside good sleep hygiene, maintain routine physical activity, manage cardiovascular risk factors, and engage in cognitive stimulation

The relationship between sleep and Alzheimer's disease remains an active area of research. While the new findings suggest that long sleep may be an early clinical sign of underlying neurodegeneration, they do not prove that sleep duration directly causes cognitive decline. Experts recommend considering sleep as part of an overall assessment of brain health, rather than viewing it in isolation.

"Because this is a snapshot in time rather than a long-term study, we cannot say that long sleep causes Alzheimer's, but the findings suggest it may be worth monitoring, and that more sleep is not always better for brain health," noted Vanessa M. Young, PhD, MS, a postdoctoral research fellow at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio.

Vanessa M. Young, PhD, MS, Postdoctoral Research Fellow at Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio

The broader lesson from recent Alzheimer's research is that biomarkers like p-tau181 and p-tau217 are useful tools for estimating risk at the group level, but they cannot serve as crystal balls for any individual's cognitive future. Just as high cholesterol increases the probability of heart disease without predicting exactly who will have a heart attack, elevated tau proteins reflect biological processes associated with Alzheimer's without guaranteeing cognitive decline. For now, the most sensible strategy remains maintaining good sleep hygiene alongside physical activity, cardiovascular health, and mental engagement.